July 13 (Reuters) - Jupiter Wellness Inc JUPW.O :
* JUPITER WELLNESS - ON JULY 12, ENTERED INTO A CLINICAL
TRIAL
RESEARCH AGREEMENT WITH APPLIED BIOLOGY, S.R.O
* JUPITER WELLNESS- AB WILL DESIGN, MANAGE AND CONDUCT A
HEAD-TO-HEAD STUDY OF JW-101 COMPARED TO EUCRISA FOR TREATMENT
OF ECZEMA
* JUPITER WELLNESS- WILL SPONSOR STUDY,UNDER PROJECTED
BUDGET LAID
OUT IN CLINICAL TRIAL RESEARCH AGREEMENT WILL PAY AB $1.1
MILLION FOR RESEARCH ACTIVITIES
* JUPITER WELLNESS INC - CLINICAL TRIAL AGREEMENT BECAME
EFFECTIVE
ON JULY 12, 2021
* JUPITER WELLNESS - INITITATION OF HEAD-TO-HEAD TRIAL
COMPARING
JW-100 AND EUCRISA® FOR TREATMENT OF MILD-TO-MODERATE ECZEMA
Source text for Eikon: [https://bit.ly/3kaAGrJ]
Further company coverage: JUPW.O
((Reuters.Briefs@thomsonreuters.com;))